Bovie Medical Corporation to Participate in Upcoming Investor Conferences
November 14 2017 - 4:05PM
Business Wire
Bovie Medical Corporation (BVX), a maker of medical
devices and supplies and the developer of J-Plasma®, a patented new
surgical product, today announced that management will participate
in the following investor conferences in November:
The 8th Annual Craig-Hallum Alpha Select Conference at the
Sheraton New York Times Square Hotel in New York, New York.
- Management will present on Thursday,
November 16 at 10:00 a.m. Eastern Time.
The Piper Jaffray 29th Annual Healthcare Conference at the Lotte
New York Palace in New York, New York.
- Management will participate in a
fireside chat on Wednesday, November 29 at 1:00 p.m. Eastern
Time.
Live audio webcasts will be provided under the ‘Company Events’
section of the Bovie Medical investor relations website at
http://www.boviemedical.com/investor_relations/. The webcasts will
be available for replay following the conferences.
About Bovie Medical
Corporation:
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma®, a patented
plasma-based surgical product for cutting, coagulation and ablation
of soft tissue. J-Plasma® utilizes a helium ionization process to
produce a stable, focused beam of plasma that provides surgeons
with greater precision, minimal invasiveness and an absence of
conductive currents through the patient during surgery. The new
J-Plasma® handpieces with Cool-Coag™ technology deliver the
precision of helium plasma energy, the power of traditional
monopolar coagulation and the efficiency of plasma beam coagulation
- enabling thin-layer ablation and dissection and fast coagulation
with a single instrument, minimizing instrument exchange and
allowing a surgeon to focus on their patient and their procedures.
With Cool-Coag technology, the new J-Plasma handpieces can deliver
three distinctly different energy modalities - further increasing
the utility and versatility of the J-Plasma system. Bovie Medical
Corporation is also a leader in the manufacture of a range of
electrosurgical products and technologies, marketed through both
private labels and the Company’s own well-respected brands (Bovie®,
IDS™ and DERM™) to distributors worldwide. The Company also
leverages its expertise through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For
further information about the Company’s current and new products,
please refer to the Investor Relations section of Bovie Medical
Corporation at www.boviemedical.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171114006590/en/
Investor Relations
Contact:Westwicke Partners on behalf of Bovie
Medical CorporationMike Piccinino,
CFA443-213-0500investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Sep 2023 to Sep 2024